|
Patient characteristics |
||||||||||||
| PNP- |
PNP+ |
|||||||||||
|
|
||||||||||||
| n |
49 |
44 |
||||||||||
| Gender (female/male) |
30/19 |
29/15 |
||||||||||
| Type of DM (1/2) |
18/31 |
9/35 |
||||||||||
| female |
male |
female |
male |
|||||||||
| Mean |
SD |
Range |
Mean |
SD |
Range |
Mean |
SD |
Range |
Mean |
SD |
Range |
|
|
|
||||||||||||
| Age (yr) |
56.3 |
9.1 |
35 |
50.9 |
9.5 |
38 |
64.9 |
8.8 |
26 |
58.8 |
10.4 |
44 |
| Duration diabetes (yr) |
13.8 |
10.2 |
36 |
11.6 |
7.7 |
31 |
18.1 |
11.4 |
38 |
16.3 |
11.4 |
42 |
| HBa1c (percent) |
8.31 |
1.5 |
4.8 |
8.15 |
1.1 |
46 |
8.25 |
1.3 |
5.5 |
8.16 |
1.3 |
6.3 |
| BMI (kg/m2) |
28.9 |
5.2 |
19.8 |
28.2 |
4.8 |
17.9 |
31.2 |
7.4 |
25.7 |
29.6 |
6.5 |
27.3 |
|
VPT = vibration perception threshold, PNP+ = peripheral polyneuropathy (VTP > 25 Volts), PNP- = no peripheral polyneuropathy (VPT ≤ 25 Volts), DM = diabetes mellitus, HbA1c = hemoglobin A1c, yr = year, BMI = Body Mass Index | ||||||||||||
Guldemond et al. BMC Endocrine Disorders 2008 8:16 doi:10.1186/1472-6823-8-16 |
||||||||||||